Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.
Healthcare conglomerate—prescription medicines, medical devices, and consumer health products.
Sector: Health care
US_JNJ
No intraday sparkline from the default exchange feed; Yahoo or day change may still appear below when available.
No price chart.
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: sec_companyfacts/200406
| Period | Issues |
|---|---|
| 2023-01-01 FY | ⚠Warn 1 |
| 2023-04-02 Q1 | ✗Errors 1Warn 5 |
| 2023-07-02 Q2 | ⚠Warn 1 |
| 2023-10-01 Q3 | ✗Errors 1Warn 1 |
| 2023-12-31 FY | ✗Errors 1Warn 2 |
| 2024-03-31 Q1 | ✗Errors 4Warn 1 |
| 2024-06-30 Q2 | ⚠Warn 1 |
| 2024-09-29 Q3 | ✗Errors 1Warn 1 |
| 2024-12-29 FY | ⚠Warn 1 |
| 2025-03-30 Q1 | ⚠Warn 2 |
| 2025-06-29 Q2 | ⚠Warn 1 |
| 2025-09-28 Q3 | ⚠Warn 1 |
| 2025-12-28 FY | ⚠Warn 1 |
| 2026-03-29 Q1 | ⚠Warn 1 |
Monetary columns are in B USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB USD | Operating profitB USD | D&AB USD | EBITDAB USD | Net profitB USD | Operating CFB USD | Capex + M&AB USD | AssetsB USD | EquityB USD | ROE (annualized) | Net debtB USD | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-29 | Q1 2026 (3M) | OK | 24.1 y/y 9.9% | 6.0 y/y -25.2% | 2.0 y/y 13.1% | 8.0 y/y -18.3% | 5.2 y/y -52.4% | 2.5 | -1.0 | 200.9 y/y 3.7% | 81.2 y/y 3.9% | 25.7% | 33.3 | Link |
| 2025-12-28 | FY 2025 (12M) | OK | 24.6 y/y 9.1% | 5.0 y/y 27.8% | 2.0 y/y 6.1% | 7.0 y/y 20.6% | 5.1 y/y 49.1% | 7.3 | -19.4 | 199.2 y/y 10.6% | 81.5 y/y 14.1% | 33.3% | 28.2 | Link |
| 2025-09-28 | Q3 2025 (3M) | OK | 24.0 y/y 6.8% | 7.5 y/y 124.5% | 1.8 y/y -3.7% | 9.3 y/y 78.8% | 5.2 y/y 91.2% | 9.2 | -1.2 | 192.8 y/y 8.1% | 79.3 y/y 13.0% | 8.7% | 27.6 | Link |
| 2025-06-29 | Q2 2025 (3M) | OK | 23.7 y/y 5.8% | 6.5 y/y 12.9% | 1.9 y/y 9.0% | 8.4 y/y 12.0% | 5.5 y/y 18.2% | 3.9 | -1.0 | 193.4 y/y 6.8% | 78.5 y/y 9.7% | 28.3% | 32.2 | Link |
| 2025-03-30 | Q1 2025 (3M) | OK | 21.9 y/y 2.4% | 8.0 y/y 1.7% | 1.8 y/y -2.4% | 9.8 y/y 0.9% | 11.0 y/y 237.9% | 4.2 | -0.8 | 193.7 y/y 12.6% | 78.1 y/y 11.6% | 58.8% | 13.8 | Link |
| 2024-12-29 | FY 2024 (12M) | OK | 22.5 y/y 5.3% | 3.9 y/y -19.5% | 1.9 y/y 2.9% | 5.8 y/y -13.3% | 3.4 y/y -15.3% | 7.0 | -1.6 | 180.1 y/y 7.5% | 71.5 y/y 3.9% | 19.9% | 12.5 | Link |
| 2024-09-29 | Q3 2024 (3M) | OK | 22.5 y/y 5.2% | 3.3 y/y -36.0% | 1.8 y/y 0.9% | 5.2 y/y -26.4% | 2.7 y/y -89.6% | 8.0 | -1.4 | 178.3 y/y 7.4% | 70.2 y/y -1.5% | 5.1% | 15.8 | Link |
| 2024-06-30 | Q2 2024 (3M) | OK | 22.4 y/y 4.3% | 5.7 y/y -8.8% | 1.8 y/y -7.9% | 7.5 y/y -8.6% | 4.7 y/y -8.9% | 5.6 | -14.0 | 181.1 y/y -5.5% | 71.5 y/y -4.8% | 26.5% | 16.6 | Link |
| 2024-03-31 | Q1 2024 (3M) | OK | 21.4 y/y 2.3% | 7.9 y/y 712.0% | 1.8 y/y -3.5% | 9.7 y/y 1534.4% | 3.3 y/y 4886.8% | 3.7 | -2.6 | 172.0 y/y -12.2% | 70.0 y/y -1.2% | 18.8% | 8.2 | Link |
| 2023-12-31 | FY 2023 (12M) | OK | 21.4 y/y — | 4.8 y/y — | 1.8 y/y — | 6.7 y/y — | 4.0 y/y — | 7.9 | -1.6 | 167.6 y/y — | 68.8 y/y — | 50.2% | 7.5 | Link |
| 2023-10-01 | Q4 2023 (3M) | OK | 21.4 y/y — | 5.2 y/y — | 1.8 y/y — | 7.0 y/y — | 26.0 y/y — | 7.5 | -1.0 | 166.1 y/y — | 71.2 y/y — | 47.4% | 10.2 | Link |
| 2023-07-02 | Q3 2023 (3M) | OK | 21.5 y/y — | 6.3 y/y — | 1.9 y/y — | 8.2 y/y — | 5.1 y/y — | 4.2 | -1.1 | 191.7 y/y — | 75.1 y/y — | 28.2% | 24.4 | Link |
| 2023-04-02 | Q2 2023 (3M) | OK | 20.9 y/y — | -1.3 y/y — | 1.9 y/y — | 0.6 y/y — | -0.1 y/y — | 3.3 | -0.9 | 196.0 y/y — | 70.9 y/y — | -0.4% | 33.7 | Link |
| 2023-01-01 | FY 2023 (12M) | OK | — y/y — | — y/y — | — y/y — | — y/y — | — y/y — | — | — | 187.4 y/y — | 76.8 y/y — | — | 26.8 | Link |
Quarterly values ($ mln)
Year-over-year change
Net debt / cash ($ mln)
Current 19.8x · 3-year average 16.2x
No dividend rows found for this issuer (checked: Yahoo Finance (ex-div)).
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)